Sorrento Therapeutics, Inc. (SRNE)

Trade SRNE now with
1/24/2018 8:16:28 AM Sorrento Therapeutics Announces Expansion Of Its GMP CAR-T Manufacturing Capacity
9/12/2017 6:03:28 AM FDA Acknowledges Receipt Of Sorrento Therapeutics NDA For ZTlido™; PDUFA Date Set For February 28, 2018
8/29/2017 6:04:02 AM Sorrento Therapeutics Submits NDA For ZTlido Next-Generation Lidocaine Patch
12/1/2016 7:28:13 AM TNK Provides Progress Update For Anti-CD38 And CD123 CAR-T Programs For Treatment Of Hematological Malignancies
9/27/2016 8:06:55 AM ARK Animal Health Submits Two Major Technical Sections Of New Animal Drug Application
9/13/2016 8:05:20 AM Sorrento Appoints Miranda Toledano As EVP Of Corporate Development, And President Of LA Cell
8/8/2016 9:05:33 AM Scintilla Enters Binding Term Sheet To Acquire SCILEX Pharmaceuticals
8/1/2016 7:03:19 AM Sorrento Therapeutics Appoints Yue Alexander Wu To Board
12/22/2015 8:34:03 AM FBR Capital Markets Initiates Sorrento Therapeutics, Inc. (SRNE) At Outperform With $22 Price Target